Market News / Story
Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Signs Licence Agreement with the University of California, San Francisco for a Phase…
TMX Newsfile ·
TMX Newsfile reports: Filament will supply PEX010 to a University of California, San Francisco trial testing whether a single dose of psilocybin can be used to help people living with HIV reduce methamphetamine use, a condition with no approved medication. Toronto, Ontario--(Newsfile Corp. - October 8, 2026) - Rhelion Life Sciences Corp. (FSE: 4YX0) (OTCQB: TRUFF) ("Rhelion" or the "Company") an Ontario-based organization advancing innovation and research within the legal psychedelic…
Related stories
Higher bond yields are raising the bar for stocks: Stan WongRead story summary
For much of this year, “higher for longer” was a warning. Now it is a market reality. With the U.S. 10-year Treasury yield above 5.25 per cent and touching a two-decade high, borrowing costs are becoming harder for markets to ignore. Bonds also compete more directly with equities for investor capital. The implications for equity valuations are significant. ...
VIEW SOURCE
ECB's Dolenc: Persistently Elevated Inflation Supports The Case For Moving Policy Rates Towards A More Restrictive TerritoryRead story summary
ECBs Dolenc: Risks Skewed To The Upside On Oil, Gas, Food, Strong Growth - Persistently Elevated Inflation Supports The Case For Moving Policy Rates Towards A More Restrictive Territory - More Stable Core Provides Some Reassurance That Broader Price Pressures Contained Ecb's Dolenc: Inflation Risks Skewed To The Upside On Oil, Gas, Food, Strong Growth ; More Stable Core Provides Some Reassurance That Broader Price Pressures Contained #oott
VIEW SOURCE
India’s central bank hikes rates for the first time since 2023 as inflation risks buildRead story summary
The Reserve Bank of India on Wednesday raised interest rates for the first time since 2023, joining several major central banks in tightening monetary policy to arrest accelerating inflation. The central bank increased the benchmark repo rate by 25 basis points to a 1-year high of 5.50%, in line with expectations of economists polled by Reuters. India’s ...
VIEW SOURCE